Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Opyl Ltd. (AU:OPL)
ASX:OPL
OPL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.03
Previous CloseN/A
Volume499.54K
Average Volume (3M)98.00K
Market Cap
AU$3.28M
Enterprise ValueAU$3.89M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Feb 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding192,968,320
10 Day Avg. Volume171,542
30 Day Avg. Volume98,002
Standard Deviation0.29
R-Squared0.19
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.94
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Opyl Ltd. News
PremiumCompany Announcements
Opyl Partners with Avion to Enhance Clinical Trial Strategies
PremiumCompany Announcements
Opyl Ltd. Unveils AI-Driven Tool to Revolutionize Clinical Trials
PremiumCompany Announcements
Opyl Limited to Host 4C Quarterly Report Webinar
PremiumCompany Announcements
Opyl Ltd. Director Saurabh Jain’s Investment ShiftPremiumCompany Announcements
Opyl Ltd. Director Increases Stake with Share Acquisition
PremiumCompany Announcements
Opyl Ltd Issues New Unquoted Equity SecuritiesPremiumCompany Announcements
Opyl Ltd. Announces New Equity Securities Issuance---
Options Prices
Currently, No data available
---
Ownership Overview
OPL FAQ
What was Opyl Ltd.’s price range in the past 12 months?
Opyl Ltd. lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is Opyl Ltd.’s market cap?
Opyl Ltd.’s market cap is AU$3.28M.
When is Opyl Ltd.’s upcoming earnings report date?
Opyl Ltd.’s upcoming earnings report date is Feb 27, 2025 which is in 4 days.
How were Opyl Ltd.’s earnings last quarter?
Opyl Ltd. released its earnings results on Aug 29, 2024. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
Is Opyl Ltd. overvalued?
According to Wall Street analysts Opyl Ltd.’s price is currently Overvalued.
Does Opyl Ltd. pay dividends?
Opyl Ltd. does not currently pay dividends.
What is Opyl Ltd.’s EPS estimate?
Opyl Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Opyl Ltd. have?
Opyl Ltd. has 192,968,320 shares outstanding.
What happened to Opyl Ltd.’s price movement after its last earnings report?
Opyl Ltd. reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Opyl Ltd.?
Currently, no hedge funds are holding shares in AU:OPL
---
Opyl Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth AU$45.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.87%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-41.99%
Trailing 12-Months
Company Description
Opyl Ltd.
Opyl Ltd provides AI-assisted technologies and guidance to biopharma and health organizations. It offers guidance in healthcare design, development, and delivery. The company invests in research and develops technologies as well as provides digital tools and insights services to healthcare, wellness, and science technology-focused clients. Its services include Opyl Services, ShareRoot Inc, Ludomade Inc, Opyl limited. The company earns the majority of revenue from the Opyl services.
---
Technical Analysis
Imugene Limited
―
PYC Therapeutics Limited
―
Race Oncology Ltd.
―
Cryosite Limited
―
Australian Clinical Labs Ltd
―
---